 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech stocks hitting 52-week highs on Dec. 11 Acceleron Pharma Inc NASDAQ: XLRN Aimmune Therapeutics Inc NASDAQ: AIMT Aprea Therapeutics Inc NASDAQ: APRE Aptose Biosciences Inc NASDAQ: APTO argenx SE ADR NASDAQ: ARGX ArQule, Inc. NASDAQ: ARQL Arvinas Inc NASDAQ: ARVN Audentes Therapeutics Inc NASDAQ: BOLD Axsome Therapeutics Inc NASDAQ: AXSM Avadel Pharmaceuticals PLC NASDAQ: AVDL Bausch Health Companies Inc NYSE: BHC BioNTech SE ADR NASDAQ: BNTX Bio-Rad Laboratories, Inc. NYSE: BIO Bristol-Myers Squibb Co NYSE: BMY Cue Biopharma Inc NASDAQ: CUE Deciphera Pharmaceuticals Inc NASDAQ: DCPH Eidos Therapeutics Inc NASDAQ: EIDX Flexion Therapeutics Inc NASDAQ: FLXN Forty Seven Inc NASDAQ: FTSV GlaxoSmithKline plc NYSE: GSK Gossamer Bio Inc NASDAQ: GOSS Immunomedics, Inc. NASDAQ: IMMU Incyte Corporation NASDAQ: INCY IVERIC bio Inc NASDAQ: ISEE Kadmon Holdings Inc NYSE: KDMN Ra Pharmaceuticals Inc NASDAQ: RARX Repro-Med Systems, Inc. 